logo-loader
RNS
viewProteome Sciences PLC

Appointment of Nominated Adviser and Broker

/**/ link{ color: blue }visited{ color: #954F72 } .u{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.u{}p.ar{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin-bottom: 13.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: center}span.ap{font-size:11.0pt; font-family:"Calibri","sans-serif";color:black}p.as{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt; margin-left:-7.1pt;text-align:justify;line-height:13.0pt}span.an{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black}p.at{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt; margin-left:-7.1pt;line-height:13.0pt}table.au{width:488.7pt;margin-left:-10.8pt;border-collapse:collapse}tr.ah{height:19.35pt}td.ai{width:477.9pt;padding:0cm 5.4pt 0cm 5.4pt; height:19.35pt} p.av{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 13.5pt}span.ak{color:black}td.af{width:264.75pt;padding:0cm 5.4pt 0cm 5.4pt; height:19.35pt}p.aw{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:13.5pt;line-height:normal}td.ae{width:202.35pt;padding:0cm 5.4pt 0cm 5.4pt; height:19.35pt}tr.aa{height:58.1pt}td.ac{width:264.75pt;padding:0cm 5.4pt 0cm 5.4pt; height:58.1pt}span.ad{font-size:10.0pt;color:black}td.ab{width:202.35pt;padding:0cm 5.4pt 0cm 5.4pt; height:58.1pt}p.ax{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt; margin-left:-7.1pt;text-align:justify;line-height:normal} a.y{font-weight: bold}p.ay{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt; margin-left:-7.1pt;text-align:justify}p.az{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify;text-autospace:none} /**/
RNS Number : 0381L
Proteome Sciences PLC
20 December 2018
 

 

20 December 2018

Proteome Sciences plc
(the "Company")

 

 Appointment of Nominated Adviser and Broker

 

The Board of Proteome Sciences plc is pleased to announce that Allenby Capital Limited has been appointed as the Company's new Nominated Adviser and sole Broker with immediate effect.

 

 For further information please contact:

Proteome Sciences plc

Dr Jeremy Haigh, Chief Executive Officer

Tel: +44 (0)20 7043 2116

Dr Ian Pike, Chief Scientific Officer

Richard Dennis, Chief Commercial Officer


 


 


 

Allenby Capital Limited (Nominated Adviser & Broker) 

John Depasquale / Jeremy Porter

 

Tel: +44 (0) 20 3328 5656

About Proteome Sciences plc. (www.proteomics.com)

Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids.  SysQuant® and TMT®MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator™ provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available.

The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
APPTLBRTMBTBBJP

Quick facts: Proteome Sciences PLC

Price: 3.25

Market: AIM
Market Cap: £9.59 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE